Initial Treatment Recommendations for Acute Gout Management
Corticosteroids should be considered as first-line therapy for acute gout attacks in patients without contraindications because they are generally safer and a low-cost treatment option with high efficacy. 1
First-Line Treatment Options
The American College of Physicians (ACP) and American College of Rheumatology (ACR) recommend three main options for treating acute gout attacks:
Corticosteroids:
NSAIDs:
Colchicine:
Treatment Algorithm
Initiate treatment as soon as possible - preferably within 24 hours of symptom onset 1
Choose medication based on:
- Patient comorbidities
- Contraindications
- Previous response to therapy
- Time since symptom onset
- Number and type of joints involved 1
For mild to moderate attacks (≤6/10 pain, 1-3 small joints or 1-2 large joints):
- Monotherapy with any of the three first-line options 1
For severe or polyarticular attacks:
- Consider combination therapy 1
Important Considerations and Precautions
Corticosteroids
- Advantages: Effective anti-inflammatory, fewer adverse effects than NSAIDs 1
- Cautions: Dysphoria, mood disorders, elevated blood glucose, immune suppression, fluid retention with long-term use 1
- Contraindications: Systemic fungal infections 1
NSAIDs
- Cautions: Dyspepsia, GI bleeding, perforations, ulcers 1
- Contraindications: Renal disease, heart failure, cirrhosis 1
- Note: No evidence that indomethacin is more effective than other NSAIDs 1
Colchicine
- Advantages: Specific for gout inflammation
- Cautions: Gastrointestinal issues (diarrhea, nausea, vomiting, cramps) 1
- Contraindications: Renal/hepatic impairment, concomitant use of CYP3A4 or P-glycoprotein inhibitors 1, 2
- Dose adjustment: Required in renal impairment, hepatic impairment, and with interacting medications 2
Common Pitfalls to Avoid
- Delaying treatment - Efficacy is highest when treatment is started within 24 hours 1
- Using high-dose colchicine - Low-dose regimen is equally effective with fewer side effects 1
- Discontinuing urate-lowering therapy during an acute attack - Continue without interruption 1
- Failing to educate patients - Patients should be educated to self-medicate at first warning symptoms 1
- Overlooking renal function - Dose adjustments are necessary for colchicine in renal impairment 2
Special Populations
Renal Impairment
- Mild to moderate impairment: No dose adjustment needed for NSAIDs or corticosteroids, but monitor closely 2
- Severe impairment: Avoid NSAIDs and adjust colchicine dosing; corticosteroids preferred 1, 2
- Dialysis patients: Colchicine reduced to 0.6 mg single dose, not repeated more than once every two weeks 2
Hepatic Impairment
- Mild to moderate impairment: No dose adjustment needed but monitor closely 2
- Severe impairment: Corticosteroids preferred; if using colchicine, do not repeat treatment more than once every two weeks 2
By following these evidence-based recommendations, acute gout attacks can be effectively managed to reduce pain, inflammation, and prevent long-term joint damage.